UNIVERSITY OF COLORADO DENVER
Exploring O-glycoproteomics to prevent metabolic radioresistance in the tumor microenvironment
Exploring O-glycoproteomics to prevent metabolic radioresistance in the tumor microenvironment is a funding opportunity from UNIVERSITY OF COLORADO DENVER, up to 249000, closing February 28, 2028.
Feb 28, 2028
(577d left)Overview
PROJECT SUMMARY Radiotherapy (RT) is often the only curative option for patients with inoperable tumors. However, radiation is also known to impair tumor metabolism, leading to radioresistance, the main reason for RT failure. Metabolic reprogramming (MR) in cancer is defined as the ability of the tumor to rewire its…